+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated Insulin Delivery System Market - Global Forecast 2026-2032- Product Image
Automated Insulin Delivery System Market - Global Forecast 2026-2032- Product Image
Sale

Automated Insulin Delivery System Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4858013
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Automated Insulin Delivery System Market is projected to reach USD 1.08 Billion in 2026. It is expected to continue growing at a CAGR of 10.09%, reaching USD 1.94 Billion by 2032.

Automated insulin delivery systems, often described as hybrid closed-loop or artificial pancreas systems, combine an insulin pump, continuous glucose monitor (CGM), dosing algorithm, and connected software to adjust insulin delivery based on real-time glucose trends. The category has moved from early type 1 diabetes innovation to a core diabetes technology segment as clinical evidence, regulatory clearances, and payer recognition expand.

Demand is grounded in a large and rising diabetes burden. The International Diabetes Federation estimated that 537 million adults were living with diabetes in 2021 and projected 643 million by 2030 and 783 million by 2045. While automated insulin delivery is most established in type 1 diabetes, interest is widening as clinicians, payers, and device developers evaluate how connected insulin management can reduce hypoglycemia, improve time in range, and support safer self-management.

Transformative Shifts in the AID Landscape

The automated insulin delivery landscape is shifting from device-centric innovation to integrated diabetes management ecosystems. Competition is increasingly shaped not only by pump hardware, but also by CGM interoperability, algorithm performance, mobile app usability, remote monitoring, cloud analytics, customer support, cybersecurity, and data integration with clinical workflows.

Regulatory and reimbursement changes are accelerating adoption. The U.S. FDA’s interoperable pathways for integrated CGMs, alternate controller enabled pumps, and automated glycemic controllers have encouraged modular system development, while broader CGM coverage in the United States has strengthened the installed base needed for AID uptake. In Europe, the transition to the Medical Device Regulation has raised evidence and post-market surveillance expectations, and the United Kingdom’s NICE recommendation for hybrid closed-loop systems in type 1 diabetes has reinforced the value case for clinically appropriate patients.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is reshaping automated insulin delivery through better personalization, predictive decision support, and population-level analytics. Current commercial AID systems rely on control algorithms that adjust basal insulin and, in some platforms, deliver correction boluses; the next wave is expected to use machine learning more extensively to identify patterns related to meals, exercise, stress, illness, sleep, and adherence.

The cumulative impact of AI will depend on evidence quality and safety governance. FDA guidance on predetermined change control plans for AI-enabled medical devices signals a pathway for controlled algorithm updates, but manufacturers must prove that adaptive features improve outcomes without increasing hypoglycemia risk. AI can also support customer service triage, device failure prediction, clinician dashboards, and behavioral coaching, creating value beyond the dosing algorithm itself.

Key Regional Insights

North America remains the most mature region for automated insulin delivery, led by the United States, where FDA-cleared AID systems, high CGM use, advanced endocrinology networks, and commercial as well as public payer coverage support adoption. Canada follows a more province-driven reimbursement model, creating uneven but improving access for insulin pump therapy, CGMs, and hybrid closed-loop systems.

Europe is a major clinical and regulatory market, with Germany, France, Italy, Spain, and the United Kingdom shaping adoption through national health systems, health technology assessment reviews, diabetes registries, and CE-marked device availability. The region’s Medical Device Regulation has increased expectations for clinical evidence, post-market surveillance, software validation, and data protection, making compliance strength a central differentiator.

Asia-Pacific is the fastest-developing opportunity as China, Japan, India, South Korea, and Australia combine large diabetes populations with expanding digital health infrastructure. Japan, South Korea, and Australia benefit from advanced specialist care and stronger CGM familiarity, while China and India present broad unmet need but face affordability, reimbursement, and diabetes educator capacity constraints. Latin America, the Middle East, and Africa show rising demand in private care and urban diabetes centers; however, reimbursement gaps, supply continuity, clinician training, and uneven access to sensors and infusion consumables limit broader use.

Key Group Insights

Within ASEAN, automated insulin delivery adoption is concentrated in private hospitals and specialist diabetes clinics in markets such as Singapore, Malaysia, and Thailand, while broader access depends on reimbursement expansion, diabetes educator capacity, and continuity of CGM and infusion set supply. GCC countries are attractive due to high diabetes prevalence, strong private-sector purchasing, and government digital health programs, particularly in Saudi Arabia and the United Arab Emirates, where connected care initiatives support remote monitoring and specialist-led diabetes management.

The European Union offers scale through harmonized CE-mark access, but country-level reimbursement and health technology assessment decisions still determine uptake. BRICS markets present significant long-term adoption potential because of population size, rising diabetes diagnosis, and increasing CGM awareness, although local pricing, distribution, regulatory approvals, and domestic manufacturing strategies are decisive. G7 countries remain the highest-value commercialization group because of advanced clinical guidelines, mature device regulation, established payer capacity, and stronger real-world evidence infrastructure. NATO markets overlap significantly with Europe and North America and increasingly emphasize procurement resilience, cybersecurity, data privacy, and supply-chain reliability for connected medical devices.

Key Country Insights

The United States is the global adoption leader for automated insulin delivery, supported by FDA-cleared systems, strong CGM use, established endocrinology networks, and a large treated type 1 diabetes population. Canada shows steady uptake, but reimbursement varies by province and affects access to pumps, CGMs, and consumables. Mexico and Brazil represent important Latin American opportunities where private-pay channels, major urban endocrinology centers, and growing awareness of diabetes technology lead adoption before broader public reimbursement develops.

In Europe, the United Kingdom is positioned for faster public-sector scale following NICE guidance for hybrid closed-loop use in type 1 diabetes, while Germany, France, Italy, and Spain are shaped by national reimbursement processes, hospital-led diabetes technology programs, and clinician training capacity. Russia remains more limited by regulatory, import, supply-chain, and reimbursement conditions, which can restrict access to advanced connected diabetes devices.

China offers large long-term potential due to population scale, rising diabetes diagnosis, digital health adoption, and domestic medtech investment, while India combines substantial unmet need with affordability challenges and uneven specialist access. Japan, South Korea, and Australia have advanced clinical infrastructures and strong CGM familiarity, making them important countries for premium systems, pediatric use, remote monitoring, and real-world evidence generation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperability, payer evidence, and patient-centered design. Systems that reduce user burden, support multiple CGM options, integrate with smartphones, and provide secure remote monitoring are better positioned as diabetes care shifts toward connected, outcomes-based management.

Manufacturers should invest in real-world evidence that demonstrates time-in-range improvement, hypoglycemia reduction, quality-of-life gains, and health-economic value. Commercial strategies should segment countries by reimbursement maturity, develop clinician and diabetes educator training programs, localize onboarding support, and build resilient supply chains for sensors, infusion sets, reservoirs, batteries, software updates, and replacement devices.

Research Methodology

Research methodology is developed using a secondary and triangulated research approach focused on verified public sources, clinical evidence, regulatory databases, and health-system policy signals. Key reference categories include International Diabetes Federation diabetes prevalence estimates, U.S. CDC diabetes statistics, FDA device classification and clearance pathways, NICE guidance, ADA Standards of Care, peer-reviewed trials, regulatory notices, reimbursement policies, and public clinical practice guidance.

Market interpretation is built by comparing disease burden, CGM penetration, reimbursement maturity, regulatory readiness, clinical infrastructure, diabetes educator availability, digital health adoption, cybersecurity expectations, and supply-chain conditions across regions and countries. Insights are validated through consistency checks across clinical outcomes, payer policy, device availability, regulatory pathways, and adoption barriers rather than relying on a single indicator.

Conclusion

Automated insulin delivery is becoming a defining technology in modern insulin-dependent diabetes care. The sector is supported by rising diabetes prevalence, strong clinical evidence for improved glycemic control, expanding CGM use, and regulatory frameworks that increasingly recognize interoperable digital medical devices.

The next phase of adoption will be determined by affordability, reimbursement, AI-enabled personalization, cybersecurity, supply continuity, clinical training, and ease of use. Organizations that combine clinically proven algorithms with patient-friendly design, scalable support models, interoperable platforms, and robust real-world evidence will be best positioned to advance the global automated insulin delivery ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Automated Insulin Delivery System Market, by Product Type
7.1. Introduction
7.2. Fully Closed Loop
7.3. Hybrid Closed Loop
7.3.1. Fuzzy Logic
7.3.2. Model Predictive Control
7.3.3. Proportional Integral Derivative
7.4. Sensor Augmented Pump
7.5. Threshold Suspend Pump
8. Automated Insulin Delivery System Market, by Component
8.1. Introduction
8.2. Continuous Glucose Monitor
8.2.1. Flash Monitoring
8.2.2. Real Time
8.3. Control Algorithm Software
8.3.1. Cloud Based
8.3.2. Mobile Based
8.4. Pump
8.4.1. Patch Pump
8.4.2. Tubed Pump
9. Automated Insulin Delivery System Market, by Insulin Type
9.1. Introduction
9.2. Rapid Acting
9.2.1. Aspart
9.2.2. Glulisine
9.2.3. Lispro
9.3. Regular U100
9.4. Ultra Rapid
9.4.1. Fiasp
9.4.2. Lyumjev
10. Automated Insulin Delivery System Market, by Technology
10.1. Introduction
10.2. Bluetooth Based
10.2.1. BLE 5.0
10.2.2. Legacy BLE
10.3. Cellular Based
10.4. WiFi Based
10.4.1. 2.4 GHz
10.4.2. 5 GHz
11. Automated Insulin Delivery System Market, by Diabetes Type
11.1. Introduction
11.2. Gestational
11.3. Type 1
11.3.1. Juvenile Onset
11.3.2. Late Autoimmune
11.4. Type 2
11.4.1. Insulin Dependent
11.4.2. Non Insulin Dependent
12. Automated Insulin Delivery System Market, by Care Setting
12.1. Introduction
12.2. Inpatient
12.2.1. General Ward
12.2.2. Intensive Care Unit
12.3. Outpatient
12.3.1. Ambulatory Daycare
12.3.2. Specialty Clinic
13. Automated Insulin Delivery System Market, by End User
13.1. Introduction
13.2. Ambulatory
13.3. Clinics
13.4. Homecare
13.4.1. Adult Users
13.4.2. Pediatric Users
13.5. Hospital
13.5.1. Ambulatory Surgical Centers
13.5.2. Inpatient
14. Automated Insulin Delivery System Market, by Distribution Channel
14.1. Introduction
14.2. Offline Pharmacy
14.3. Online Pharmacy
15. Automated Insulin Delivery System Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Automated Insulin Delivery System Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Automated Insulin Delivery System Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Ascensia Diabetes Care Holdings AG
19.3. Becton, Dickinson and Company
19.4. Beta Bionics, Inc.
19.5. Bigfoot Biomedical, Inc.
19.6. CamDiab Limited
19.7. Cellnovo Group S.A.
19.8. Companion Medical, Inc.
19.9. Dexcom, Inc.
19.10. Diabeloop S.A.
19.11. DreaMed Diabetes Ltd.
19.12. Eli Lilly and Company
19.13. EOFlow Co., Ltd.
19.14. F. Hoffmann-La Roche Ltd
19.15. Glooko, Inc.
19.16. i-SENS, Inc.
19.17. Insulcloud S.L.
19.18. Insulet Corporation
19.19. Medtronic plc
19.20. Medtrum Technologies Inc.
19.21. MicroTech Medical (Hangzhou) Co., Ltd.
19.22. Novo Nordisk A/S
19.23. Pancreum, Inc.
19.24. Pendiq GmbH
19.25. Roche Diabetes Care GmbH
19.26. Sanofi S.A.
19.27. Senseonics Holdings, Inc.
19.28. Sequel Med Tech, LLC
19.29. Sinocare Inc.
19.30. SOOIL Development Co., Ltd.
19.31. Tandem Diabetes Care, Inc.
19.32. Tidepool Project
19.33. TypeZero Technologies, LLC
19.34. Valeritas Holdings, Inc.
19.35. Ypsomed Holding AG
20. Key Experts
List of Figures
FIGURE 1. Global Automated Insulin Delivery System Market, Years Considered for the Study
FIGURE 2. Global Automated Insulin Delivery System Market, Research Design
FIGURE 3. Global Automated Insulin Delivery System Market, Research Framework
FIGURE 4. Global Automated Insulin Delivery System Market, Data Triangulation
FIGURE 5. Global Automated Insulin Delivery System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Automated Insulin Delivery System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Automated Insulin Delivery System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Automated Insulin Delivery System Market Size, by Component, 2025 vs 2032 (%)
FIGURE 9. Global Automated Insulin Delivery System Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Automated Insulin Delivery System Market Size, by Insulin Type, 2025 vs 2032 (%)
FIGURE 11. Global Automated Insulin Delivery System Market Size, by Insulin Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Automated Insulin Delivery System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 13. Global Automated Insulin Delivery System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Automated Insulin Delivery System Market Size, by Diabetes Type, 2025 vs 2032 (%)
FIGURE 15. Global Automated Insulin Delivery System Market Size, by Diabetes Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Automated Insulin Delivery System Market Size, by Care Setting, 2025 vs 2032 (%)
FIGURE 17. Global Automated Insulin Delivery System Market Size, by Care Setting, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Automated Insulin Delivery System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Automated Insulin Delivery System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Automated Insulin Delivery System Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Automated Insulin Delivery System Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Automated Insulin Delivery System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Automated Insulin Delivery System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Automated Insulin Delivery System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Automated Insulin Delivery System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Automated Insulin Delivery System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Automated Insulin Delivery System Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Automated Insulin Delivery System Market Segmentation & Coverage
TABLE 2. Global Automated Insulin Delivery System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Fully Closed Loop Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Fully Closed Loop Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Fully Closed Loop Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Hybrid Closed Loop Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Hybrid Closed Loop Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Hybrid Closed Loop Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fuzzy Logic Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fuzzy Logic Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fuzzy Logic Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Model Predictive Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Model Predictive Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Model Predictive Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Proportional Integral Derivative Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Proportional Integral Derivative Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Proportional Integral Derivative Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Sensor Augmented Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Sensor Augmented Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Sensor Augmented Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Threshold Suspend Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Threshold Suspend Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Threshold Suspend Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 26. Global Continuous Glucose Monitor Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Continuous Glucose Monitor Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Continuous Glucose Monitor Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Flash Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Flash Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Flash Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Real Time Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Real Time Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Real Time Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Control Algorithm Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Control Algorithm Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Control Algorithm Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Cloud Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Cloud Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Cloud Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Mobile Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Mobile Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Mobile Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Patch Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Patch Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Patch Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Tubed Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Tubed Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Tubed Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 54. Global Rapid Acting Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Rapid Acting Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Rapid Acting Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Aspart Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Aspart Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Aspart Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Glulisine Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Glulisine Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Glulisine Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Lispro Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Lispro Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Lispro Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Regular U100 Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Regular U100 Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Regular U100 Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Ultra Rapid Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Ultra Rapid Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Ultra Rapid Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Fiasp Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Fiasp Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Fiasp Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Lyumjev Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Lyumjev Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Lyumjev Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 79. Global Bluetooth Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Bluetooth Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Bluetooth Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global BLE 5.0 Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global BLE 5.0 Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global BLE 5.0 Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Legacy BLE Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Legacy BLE Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Legacy BLE Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Cellular Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Cellular Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Cellular Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global WiFi Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global WiFi Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global WiFi Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global 2.4 GHz Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global 2.4 GHz Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global 2.4 GHz Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global 5 GHz Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global 5 GHz Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global 5 GHz Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 101. Global Gestational Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Gestational Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Gestational Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Type 1 Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Type 1 Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Type 1 Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Juvenile Onset Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Juvenile Onset Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Juvenile Onset Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Late Autoimmune Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Late Autoimmune Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Late Autoimmune Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Type 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Type 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Type 2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Insulin Dependent Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Insulin Dependent Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Insulin Dependent Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Non Insulin Dependent Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Non Insulin Dependent Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Non Insulin Dependent Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 123. Global Inpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Inpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Inpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global General Ward Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global General Ward Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global General Ward Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Intensive Care Unit Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Intensive Care Unit Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Intensive Care Unit Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Outpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Outpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Outpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Ambulatory Daycare Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Ambulatory Daycare Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Ambulatory Daycare Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Global Ambulatory Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Ambulatory Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Ambulatory Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Homecare Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Homecare Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Homecare Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Adult Users Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Adult Users Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Adult Users Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Pediatric Users Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Pediatric Users Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Pediatric Users Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Inpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Inpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Inpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Global Offline Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Offline Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Offline Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 183. Asia-Pacific Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 184. Asia-Pacific Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. Asia-Pacific Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. North America Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 198. North America Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. North America Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 200. North America Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 201. North America Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 202. North America Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 203. North America Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 204. North America Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 205. North America Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 206. North America Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 207. North America Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. North America Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 209. North America Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 210. North America Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 211. North America Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 212. North America Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 213. North America Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 214. North America Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 215. North America Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 216. North America Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. North America Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 218. North America Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 219. North America Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. Latin America Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 221. Latin America Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Latin America Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 223. Latin America Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 224. Latin America Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 225. Latin America Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 226. Latin America Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 227. Latin America Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 228. Latin America Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 229. Latin America Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 230. Latin America Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. Latin America Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 232. Latin America Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 233. Latin America Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 234. Latin America Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 235. Latin America Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 236. Latin America Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 237. Latin America Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 238. Latin America Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 239. Latin America Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Latin America Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 241. Latin America Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 242. Latin America Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. Europe Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Europe Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Europe Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 246. Europe Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 247. Europe Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 248. Europe Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 249. Europe Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 250. Europe Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 251. Europe Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 252. Europe Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 253. Europe Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 254. Europe Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 255. Europe Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 256. Europe Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 257. Europe Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 258. Europe Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 259. Europe Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 260. Europe Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 261. Europe Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 262. Europe Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Europe Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 264. Europe Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 265. Europe Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. Middle East Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 267. Middle East Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. Middle East Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 269. Middle East Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 270. Middle East Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 271. Middle East Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 272. Middle East Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 273. Middle East Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 274. Middle East Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 275. Middle East Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 276. Middle East Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. Middle East Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 278. Middle East Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 279. Middle East Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 280. Middle East Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 281. Middle East Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 282. Middle East Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 283. Middle East Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 284. Middle East Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 285. Middle East Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Middle East Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 287. Middle East Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 288. Middle East Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. Africa Automated Insulin Delivery System Market Size, by Region, 2017-2032 (USD Million)
TABLE 290. Africa Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. Africa Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 292. Africa Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 293. Africa Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 294. Africa Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 295. Africa Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 296. Africa Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 297. Africa Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 298. Africa Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 299. Africa Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 300. Africa Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 301. Africa Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 302. Africa Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 303. Africa Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 304. Africa Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 305. Africa Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 306. Africa Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 307. Africa Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 308. Africa Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Africa Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 310. Africa Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 311. Africa Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. Global Automated Insulin Delivery System Market Size, by Group, 2017-2032 (USD Million)
TABLE 313. ASEAN Automated Insulin Delivery System Market Size, by Group, 2017-2032 (USD Million)
TABLE 314. ASEAN Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. ASEAN Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 316. ASEAN Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 317. ASEAN Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 318. ASEAN Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 319. ASEAN Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 320. ASEAN Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 321. ASEAN Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 322. ASEAN Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 323. ASEAN Automated Insulin Delivery System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 324. ASEAN Automated Insulin Delivery System Market Size, by Bluetooth Based, 2017-2032 (USD Million)
TABLE 325. ASEAN Automated Insulin Delivery System Market Size, by WiFi Based, 2017-2032 (USD Million)
TABLE 326. ASEAN Automated Insulin Delivery System Market Size, by Diabetes Type, 2017-2032 (USD Million)
TABLE 327. ASEAN Automated Insulin Delivery System Market Size, by Type 1, 2017-2032 (USD Million)
TABLE 328. ASEAN Automated Insulin Delivery System Market Size, by Type 2, 2017-2032 (USD Million)
TABLE 329. ASEAN Automated Insulin Delivery System Market Size, by Care Setting, 2017-2032 (USD Million)
TABLE 330. ASEAN Automated Insulin Delivery System Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 331. ASEAN Automated Insulin Delivery System Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 332. ASEAN Automated Insulin Delivery System Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. ASEAN Automated Insulin Delivery System Market Size, by Homecare, 2017-2032 (USD Million)
TABLE 334. ASEAN Automated Insulin Delivery System Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 335. ASEAN Automated Insulin Delivery System Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 336. GCC Automated Insulin Delivery System Market Size, by Group, 2017-2032 (USD Million)
TABLE 337. GCC Automated Insulin Delivery System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 338. GCC Automated Insulin Delivery System Market Size, by Hybrid Closed Loop, 2017-2032 (USD Million)
TABLE 339. GCC Automated Insulin Delivery System Market Size, by Component, 2017-2032 (USD Million)
TABLE 340. GCC Automated Insulin Delivery System Market Size, by Continuous Glucose Monitor, 2017-2032 (USD Million)
TABLE 341. GCC Automated Insulin Delivery System Market Size, by Control Algorithm Software, 2017-2032 (USD Million)
TABLE 342. GCC Automated Insulin Delivery System Market Size, by Pump, 2017-2032 (USD Million)
TABLE 343. GCC Automated Insulin Delivery System Market Size, by Insulin Type, 2017-2032 (USD Million)
TABLE 344. GCC Automated Insulin Delivery System Market Size, by Rapid Acting, 2017-2032 (USD Million)
TABLE 345. GCC Automated Insulin Delivery System Market Size, by Ultra Rapid, 2017-2032 (USD Million)
TABLE 346. GCC Automated Insulin Delivery System Market Si

Companies Mentioned

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Becton, Dickinson and Company
  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • CamDiab Limited
  • Cellnovo Group S.A.
  • Companion Medical, Inc.
  • Dexcom, Inc.
  • Diabeloop S.A.
  • DreaMed Diabetes Ltd.
  • Eli Lilly and Company
  • EOFlow Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Glooko, Inc.
  • i-SENS, Inc.
  • Insulcloud S.L.
  • Insulet Corporation
  • Medtronic plc
  • Medtrum Technologies Inc.
  • MicroTech Medical (Hangzhou) Co., Ltd.
  • Novo Nordisk A/S
  • Pancreum, Inc.
  • Pendiq GmbH
  • Roche Diabetes Care GmbH
  • Sanofi S.A.
  • Senseonics Holdings, Inc.
  • Sequel Med Tech, LLC
  • Sinocare Inc.
  • SOOIL Development Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Tidepool Project
  • TypeZero Technologies, LLC
  • Valeritas Holdings, Inc.
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages193
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.08 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.94 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned35

Related Topics

Related Reports

Insulin Pumps Market - Global Forecast 2026-2032 - Product Image

Insulin Pumps Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032 - Product Image

Continuous Subcutaneous Insulin Infusion Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Insulin Delivery Device - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Insulin Delivery Device - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Smart Insulin Pens and Pumps - Global Strategic Business Report - Product Image

Smart Insulin Pens and Pumps - Global Strategic Business Report

  • Report
  • 131 Pages
  • Global
From
Global Insulin Delivery Devices Market Overview, 2026-2031 - Product Image

Global Insulin Delivery Devices Market Overview, 2026-2031

  • Report
  • 97 Pages
  • Global
From

About the Automated Insulin Delivery Market

The Automated Insulin Delivery (AID) market is a subset of the larger diabetes devices market. AID systems are designed to help people with diabetes manage their condition by automatically delivering insulin to the body. These systems are typically composed of an insulin pump, a continuous glucose monitor (CGM), and a control algorithm. The CGM measures glucose levels in the body and sends the data to the control algorithm, which then calculates the amount of insulin needed and sends a signal to the insulin pump to deliver the appropriate dose. AID systems are designed to provide more accurate and consistent insulin delivery than traditional methods, and can help reduce the risk of hypoglycemia and other diabetes-related complications. They are also designed to be user-friendly and provide users with more control over their diabetes management. Some companies in the AID market include Medtronic, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, and Senseonics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.